Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed cuts rates amid policy split, plans balance sheet changes to stabilize liquidity
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.